Apr. 24 at 6:21 PM
$ACLX Equity Corporate Actions Alert #2026 - 272
Information Regarding the Merger of Arcellx, Inc. (ACLX)
https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2026-272
The tender offer by Gilead Sciences, Inc.
$GILD to acquire all of the outstanding common stock of Arcellx, Inc.
$ACLX is scheduled to expire at 5:00 p.m. ET, on April 27, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on April 28, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on April 27, 2026. If the merger closes as anticipated, the stock will remain halted on the day of closing (April 28th) and will be suspended effective April 29, 2026. The details are as follows:
